BioNeutra Global Corporation
BGACF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $4 | $1 |
| - Cash | $1 | $0 | $0 | $2 |
| + Debt | $8 | $8 | $6 | $8 |
| Enterprise Value | $10 | $11 | $9 | $7 |
| Revenue | $3 | $3 | $2 | $3 |
| % Growth | 15.1% | 7.8% | -9% | – |
| Gross Profit | $1 | $1 | -$0 | $2 |
| % Margin | 27.6% | 30.9% | -1.9% | 61.4% |
| EBITDA | -$0 | -$0 | -$0 | $2 |
| % Margin | -5.3% | -13% | -16.5% | 69.4% |
| Net Income | -$0 | -$1 | -$1 | $1 |
| % Margin | -13.5% | -28.6% | -33.9% | 51.5% |
| EPS Diluted | -0.01 | -0.016 | -0.018 | 0.03 |
| % Growth | 38.7% | 8.9% | -159.7% | – |
| Operating Cash Flow | $0 | $0 | -$1 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | -$1 | -$0 |